Tests that feature genomic indicators can now be used to guide the pharmacological treatment of patients. To better identify the needs and preferences of patients and health care providers in facilitating their understanding of information related to such pharmacogenomic tests (PGx), a review of literature on knowledge translation and health literacy in the context of testing was conducted. Using a grounded theory-based approach, a comparative analysis of data from 36 studies meeting the criteria for the meta-data analysis has revealed the recurrence of three principal themes: (a) knowledge and understanding of genetics and pharmacogenomics; (b) experiences with genetic, genomic, or PGx testing (decision about the test, information delivery, and understanding of test results); and (c) educational/informational resources. This synthesis sheds light on each theme from the standpoint of both patients and health care providers and suggests avenues in which to direct efforts to support the introduction of pharmacogenomic tests in current practice.
AndersonA. E.FloresK. G.BoonyasiriwatW.GammonA.KohlmannW.BirminghamW. C.. . . KinneyA. Y. (2014). Interest and informational preferences regarding genomic testing for modest increases in colorectal cancer risk. Public Health Genomics, 17, 48–60. doi:10.1159/000356567
2.
BakerD. W. (2006). The meaning and the measure of health literacy. Journal of General Internal Medicine, 21, 878–883. doi:10.1111/j.1525-1497.2006.00540.x
3.
BerkmanN. D.SheridanS. L.DonahueK. E.HalpernD. J.CrottyK. (2011). Low health literacy and health outcomes: An updated systematic review. Annals of Internal Medicine, 155, 97–107. doi:10.7326/0003-4819-155-2-201107190-00005
4.
BermE. J. J.de LooffM.WilffertB.BoersmaC.AnnemansL.VegterS.. . . PostmaM. J. (2016). Economic evaluations of pharmacogenetic and pharmacogenomic screening tests: A systematic review. Second update of the literature. PLoS ONE, 11(1), e0146262. doi:10.1371/journal.pone.0146262
5.
BordenB. A.GaleckiP.WellmannR.DanaheyK.LeeS. M.Patrick-MillerL.. . . O’DonnellP. H. (2019). Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study. Pharmacogenetics and Genomics, 29(2), 31–38. doi:10.1097/FPC.0000000000000362
6.
BregaA. G.BarnardJ.MabachiN. M.WeissB. D.DeWaltD. A.BrachC.. . . WestD. R. (2015). AHRQ health literacy universal precautions toolkit (2nd ed.). Rockville, MD: Agency for Healthcare Research and Quality.
7.
CalzoneK. A.CashionA.FeethamS.JenkinsJ.ProwsC. A.WilliamsJ. K.WungS.-F. (2010). Nurses transforming health care using genetics and genomics. Nursing Outlook, 58, 26–35. doi:10.1016/j.outlook.2009.05.001
8.
CalzoneK. A.KirkM.TonkinE.BadzekL.BenjaminC.MiddletonA. (2018). The global landscape of nursing and genomics. Journal of Nursing Scholarship, 50, 249–256. doi:10.1111/jnu.12380
9.
CaraballoP. J.HodgeL. S.BielinskiS. J.StewartA. K.FarrugiaG.SchultzC. G.. . . WeinshilboumR. M. (2017). Multidisciplinary model to implement pharmacogenomics at the point of care. Genetics in Medicine, 19, 421–429. doi:10.1038/gim.2016.120
10.
CaudleK. E.DunnenbergerH. M.FreimuthR. R.PetersonJ. F.BurlisonJ. D.Whirl-CarrilloM.. . . HoffmanJ. M. (2017). Standardizing terms for clinical pharmacogenetic test results: Consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC). Genetics in Medicine, 19, 215–223. doi:10.1038/gim.2016.87
11.
CavallariL. H.BeitelsheesA. L.BlakeK. V.DresslerL. G.DuarteJ. D.ElseyA.. . . JohnsonJ. A. (2017). The IGNITE Pharmacogenetics Working Group: An opportunity for building evidence with pharmacogenetic implementation in a real-world setting. Clinical and Translational Science, 10, 143–146. doi:10.1111/cts.12456
12.
ChamplinS.MackertM.GlowackiE. M.DonovanE. E. (2017). Toward a better understanding of patient health literacy: A focus on the skills patients need to find health information. Qualitative Health Research, 27, 1160–1176. doi:10.1177/1049732316646355
13.
ChristensenK. D.VassyJ. L.JamalL.LehmannL. S.SlashinskiM. J.PerryD. L.. . . McGuireA. L. (2016). Are physicians prepared for whole genome sequencing? A qualitative analysis. Clinical Genetics, 89, 228–234. doi:10.1111/cge.12626
14.
ColemanC.HudsonS.MaineL. L. (2013). Health literacy practices and educational competencies for health professionals: A consensus study. Journal of Health Communication, 18(Suppl. 1), 82–102. doi:10.1080/10810730.2013.829538
ConditC. M. (2010). Public understandings of genetics and health. Clinical Genetics, 77, 1–9. doi:10.1111/j.1399-0004.2009.01316.x
17.
Daack-HirschS.ShahL. L.CadyA. D. (2018). Mental models of cause and inheritance for type 2 diabetes among unaffected individuals who have a positive family history. Qualitative Health Research, 28, 534–547. doi:10.1177/1049732317745052
18.
DavisT. C.WilliamsM. V.MarinE.ParkerR. M.GlassJ. (2002). Health literacy and cancer communication. CA: A Cancer Journal for Clinicians, 52, 134–149. doi:10.3322/canjclin.52.3.134
19.
DodsonC. (2018). Oncology nurses’ knowledge of pharmacogenomics before and after implementation of an education module. Oncology Nursing Forum, 45, 575–580. doi:10.1188/18.Onf.575-580
20.
DunnenbergerH. M.BiszewskiM.BellG. C.SereikaA.MayH.JohnsonS. G.. . . KhandekarJ. (2016). Implementation of a multidisciplinary pharmacogenomics clinic in a community health system. American Journal of Health-system Pharmacists, 73, 1956–1966. doi:10.2146/ajhp160072
21.
FentonG. L.SmitA. K.FreemanL.BadcockC.DunlopK.ButowP. N.. . . CustA. E. (2018). Development and evaluation of a telephone communication protocol for the delivery of personalized melanoma genomic risk to the general population. Journal of Genetic Counseling, 27, 370–380. doi:10.1007/s10897-017-0183-7
22.
FinfgeldD. L. (2003). Metasynthesis: The state of the art—So far. Qualitative Health Research, 13(7), 893–904. doi:10.1177/1049732303253462
23.
GlaserB. G.StraussA. (2009). The discovery of grounded theory: Strategies for qualitative research. Piscataway, NJ: Aldine Transaction.
24.
HagaS. B.MillsR. (2015). Nurses’ communication of pharmacogenetic test results as part of discharge care. Pharmacogenomics, 16, 251–256. doi:10.2217/pgs.14.173
25.
HagaS. B.MillsR.MoaddebJ. (2016a). Evaluation of a pharmacogenetic educational toolkit for community pharmacists. Pharmacogenomics, 17, 1491–1502. doi:10.2217/pgs-2016-0002
26.
HagaS. B.MillsR.MoaddebJ.Allen LaPointeN.ChoA.GinsburgG. S. (2016b). Patient experiences with pharmacogenetic testing in a primary care setting. Pharmacogenomics, 17, 1629–1636. doi:10.2217/pgs-2016-0077
27.
HagaS. B.MillsR.MoaddebJ.Allen LaPointeN.ChoA.GinsburgG. S. (2017). Primary care providers’ use of pharmacist support for delivery of pharmacogenetic testing. Pharmacogenomics, 18, 359–367. doi:10.2217/pgs-2016-0177
28.
HagaS. B.MoaddebJ.MillsR.PatelM.KrausW.Allen LaPointeN. M. (2015). Incorporation of pharmacogenetic testing into medication therapy management. Pharmacogenomics, 16, 1931–1941. doi:10.2217/pgs.15.124
29.
HosslerD.Scalese-LoveP. (1989). Grounded meta-analysis: A guide for research synthesis. The Review of Higher Education, 13, 1–28. doi:10.1353/rhe.1989.0000
30.
JacksonL.O’ConnorA.PanequeM.CurtisovaV.LuntP. W.PourovaR. K.. . . CornelM. C. (2019). The Gen-Equip Project: Evaluation and impact of genetics e-learning resources for primary care in six European languages. Genetics in Medicine, 21, 718–726. doi:10.1038/s41436-018-0132-3
31.
JosephG.BeattieM. S.LeeR.BraithwaiteD.WilcoxC.MetrikinM.. . . LuceJ. (2010). Pre-counseling education for low literacy women at risk of hereditary breast and ovarian cancer (HBOC): Patient experiences using the Cancer Risk Education Intervention Tool (CREdIT). Journal of Genetic Counseling, 19, 447–462. doi:10.1007/s10897-010-9303-3
32.
JosephG.LeeR.PasickR. J.GuerraC.SchillingerD.RubinS. (2018). Effective communication in the era of precision medicine: A pilot intervention with low health literacy patients to improve genetic counseling communication. European Journal of Medical Genetics, 62, 357-367. doi:10.1016/j.ejmg.2018.12.004
33.
JosephG.PasickR. J.SchillingerD.LuceJ.GuerraC.ChengJ. K. Y. (2017). Information mismatch: Cancer risk counseling with diverse underserved patients. Journal of Genetic Counseling, 26, 1090–1104. doi:10.1007/s10897-017-0089-4
34.
JustK. S.SteffensM.SwenJ. J.PatrinosG. P.GuchelaarH.-J.StinglJ. C. (2017). Medical education in pharmacogenomics-results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx). European Journal of Clinical Pharmacology, 73, 1247–1252. doi:10.1007/s00228-017-2292-5
35.
KeF. (2009). A qualitative meta-analysis of computer games as learning tools. In FerdigR. E. (Ed.), Handbook of research on effective electronic gaming in education (pp. 1–32). London: IGI Global.
36.
KickbuschI.MaagD. (2008). Health literacy. In HeggenhougenH. K.QuahS. R. (Eds.), International encyclopedia of public health (pp. 204–211). San Diego: Academic Press.
37.
KorngiebelD. M.WestK. M.BurkeW. (2018). Clinician-stakeholders’ perspectives on using patient portals to return Lynch syndrome screening results. Journal of Genetic Counseling, 27, 349–357. doi:10.1007/s10897-017-0179-3
38.
KrakowM.RatcliffC. L.HesseB. W.Greenberg-WorisekA. J. (2017). Assessing Genetic Literacy Awareness and Knowledge Gaps in the US Population: Results from the Health Information National Trends Survey. Public Health Genomics, 20, 343-348. doi: 10.1159/000489117
39.
LachanceC. R.ErbyL. A. H.FordB. M.AllenV. C.KaphingstK. A.Jr. (2010). Informational content, literacy demands, and usability of websites offering health-related genetic tests directly to consumers. Genetics in Medicine, 12, 304–312. doi:10.1097/GIM.0b013e3181dbd8b2
40.
LanieA. D.JayaratneT. E.SheldonJ. P.KardiaS. L. R.AndersonE. S.FeldbaumM.PettyE. M. (2004). Exploring the public understanding of basic genetic concepts. Journal of Genetic Counseling, 13, 305–320. doi:10.1023/b:jogc.0000035524.66944.6d
41.
LeaD. H.KaphingstK.BowenD.LipkusI.HadleyD. W. (2011). Communicating genetic and genomic information: Health literacy and numeracy considerations. Public Health Genomics, 14, 279–289. doi:10.1159/000294191
42.
LeeY. M.ManzoorB. S.CavallariL. H.NutescuE. A. (2018). Facilitators and barriers to the adoption of pharmacogenetic testing in an inner-city population. Pharmacotherapy, 38, 205–216. doi:10.1002/phar.2077
43.
LeeY. M.McKillipR. P.BordenB. A.KlammerC. E.RatainM. J.O’DonnellP. H. (2017). Assessment of patient perceptions of genomic testing to inform pharmacogenomic implementation. Pharmacogenetics and Genomics, 27, 179–189. doi:10.1097/FPC.0000000000000275
44.
LemkeA. A.HulickP. J.WakeD. T.WangC.SereikaA. W.YuK. D.. . . DunnenbergerH. M. (2018). Patient perspectives following pharmacogenomics results disclosure in an integrated health system. Pharmacogenomics, 19, 321–331. doi:10.2217/pgs-2017-0191
45.
LiangM. I.WongD. H.WalshC. S.Farias-EisnerR.CohenJ. G. (2018). Cancer genetic counseling and testing: Perspectives of epithelial ovarian cancer patients and gynecologic oncology healthcare providers. Journal of Genetic Counseling, 27, 177–186. doi:10.1007/s10897-017-0135-2
46.
LubitzR. J.KomaromyM.CrawfordB.BeattieM. S.LeeR.LuceJ.ZieglerJ. (2007). Development and pilot evaluation of novel genetic educational materials designed for an underserved patient population. Genetic Testing, 11, 276–290. doi:10.1089/gte.2007.0012
47.
MaloneyK. A.AlaeddinD. S.von CoellnR.DixonS.ShulmanL. M.SchraderK.GuanY. (2018). Parkinson’s disease: Patients’ knowledge, attitudes, and interest in genetic counseling. Journal of Genetic Counseling, 27, 1200–1209. doi:10.1007/s10897-018-0239-3
48.
MillsR.EnsingerM.CallananN.HagaS. B. (2017). Development and initial assessment of a patient education video about pharmacogenetics. Journal of Personalized Medicine, 7(2), E4. doi:10.3390/jpm7020004
49.
MoaddebJ.MillsR.HagaS. B. (2015). Community pharmacists’ experience with pharmacogenetic testing. Journal of the American Pharmacists Association, 55, 587–594. doi:10.1331/JAPhA.2015.15017
50.
National Academies of Sciences, Engineering, & Medicine. (2016). Relevance of health literacy to precision medicine: Proceedings of a workshop. Washington, DC: The National Academies Press.
51.
National Institutes of Health. (2018). Help me understand genetics. Genetics Home Reference. Retrieved from https://ghr.nlm.nih.gov/primer
52.
NavarrodeSouzaA.GroleauD.LoiselleC. G.FoulkesW. D.WongN. (2014). Cultural aspects of healthy BRCA carriers from two ethnocultural groups. Qualitative Health Research, 24, 665–681. doi:10.1177/1049732314528756
53.
Nielsen-BohlmanL.PanzerA. M.KindigD. A. (Eds.). (2004). Health literacy: A prescription to end confusion. Washington, DC: Institute of Medicine, National Academies Press.
54.
NusbaumR.LeventhalK.-G.HookerG. W.PeshkinB. N.ButrickM.SalehizadehY.. . . GravesK. D. (2013). Translational genomic research: Protocol development and initial outcomes following SNP testing for colon cancer risk. Translational Behavioral Medicine, 3, 17–29. doi:10.1007/s13142-012-0149-0
55.
ObengA. O.FeiK.LevyK. D.ElseyA. R.PollinT. I.RamirezA. H.. . . HorowitzC. R. (2018). Physician-reported benefits and barriers to clinical implementation of genomic medicine: A multi-site IGNITE-network survey. Journal of Personalized Medicine, 8(3), 24. doi:10.3390/jpm8030024
56.
OlsonJ. E.Rohrer VitekC. R.BellE. J.McGreeM. E.JacobsonD. J.St. SauverJ. L.. . . BielinskiS. J. (2017). Participant-perceived understanding and perspectives on pharmacogenomics: The Mayo Clinic RIGHT protocol (Right Drug, Right Dose, Right Time). Genetics in Medicine, 19, 819–825. doi:10.1038/gim.2016.192
57.
PatersonB. L. (2001). The shifting perspectives model of chronic illness. Journal of Nursing Scholarship, 33, 21–26. doi:10.1111/j.1547-5069.2001.00021.x
58.
PatersonB. L.ThorneS. E.CanamC.JillingsC. (2001). Meta-study of qualitative health research: A practical guide to meta-analysis and meta-synthesis. Thousand Oaks, CA: Sage.
59.
PleasantA.RuddR.O’LearyC.Paasche-OrlowM. K.AllenM. P.Alvarado-LittleW.. . . RosenS. (2016). Considerations for a new definition of health literacy. NAM Perspectives. Washington, DC: National Academy of Medicine. doi:10.31478/201604a
60.
RogersC. R.RovitoM. J.HusseinM.ObidikeO. J.PrattR.AlexanderM.. . . WarlickC. (2018). Attitudes toward genomic testing and prostate cancer research among black men. American Journal of Preventive Medicine, 55(5, Suppl. 1), S103–S111. doi:10.1016/j.amepre.2018.05.028
61.
Rohrer VitekC. R.NicholsonW. T.SchultzC.CaraballoP. J. (2015). Evaluation of the use of clinical decision support and online resources for pharmacogenomics education. Pharmacogenomics, 16, 1595–1603. doi:10.2217/pgs.15.100
62.
SchillingerD.PietteJ.GrumbachK.WangF.WilsonC.DaherC. (2003). Closing the loop: Physician communication with diabetic patients who have low health literacy. Archives of Internal Medicine, 163, 83–90. doi:10.1001/archinte.163.1.83
63.
SchreiberR.CrooksD.SternP. N. (1997). Qualitative meta-analysis. In MorseJ. M. (Ed.), Completing a qualitative project: Details and dialogue (pp. 311–326). Thousand Oaks, CA: Sage.
64.
SilversteinL. B.StolermanM.HidayatallahN.McDonaldT.WalshC. A.PaljevicE.. . . DolanS. M. (2014). Translating advances in cardiogenetics into effective clinical practice. Qualitative Health Research, 24, 1315–1328. doi:10.1177/1049732314546754
65.
SmitA. K.KeoghL. A.HerschJ.NewsonA. J.ButowP.WilliamsG.CustA. E. (2016). Public preferences for communicating personal genomic risk information: A focus group study. Health Expectations, 19, 1203–1214. doi:10.1111/hex.12406
66.
SorensenK.Van Den BrouckeS.FullamJ.DoyleG.PelikanJ.SlonskaZ.BrandH. (2012). Health literacy and public health: A systematic review and integration of definitions and models. Biomed Central Public Health, 12, Article 80. doi:10.1186/1471-2458-12-80
67.
StrausS. E.TetroeJ. M.GrahamI. D. (2011). Knowledge translation is the use of knowledge in health care decision making. Journal of Clinical Epidemiology, 64, 6–10. doi:10.1016/j.jclinepi.2009.08.016
68.
StraussA.CorbinJ. (1990). Basics of qualitative research: Grounded theory procedures and techniques. Newbury Park, CA: Sage.
69.
SyurinaE. V.BrandkovicI.Probst-HenschN.BrandA. (2011). Genome-based health literacy: A new challenge for public health genomics. Public Health Genomics, 14, 201–210. doi:10.1159/000324238
70.
TomlinsonA. N.SkinnerD.PerryD. L.ScollonS. R.RocheM. I.BernhardtB. A. (2016). “Not tied up neatly with a bow”: Professionals’ challenging cases in informed consent for genomic sequencing. Journal of Genetic Counseling, 25, 62–72. doi:10.1007/s10897-015-9842-8
71.
UnertlK. M.FieldJ. R.PriceL.PetersonJ. F. (2015). Clinician perspectives on using pharmacogenomics in clinical practice. Personalized Medicine, 12, 339–347. doi:10.2217/pme.15.10
72.
van der WoudenC. H.Cambon-ThomsenA.CecchinE.CheungK. C.Davila-FajardoC. L.DeneerV. H.. . . GuchelaarH. J. (2017). Implementing pharmacogenomics in Europe: Design and implementation strategy of the Ubiquitous Pharmacogenomics Consortium. Clinical Pharmacology and Therapeutics, 101, 341–358. doi:10.1002/cpt.602
73.
VegterS.JansenE.PostmaM. J.BoersmaC. (2010). Economic evaluations of pharmacogenetic and genomic screening programs: Update of the literature. Drug Development Research, 71, 492–501. doi:10.1002/ddr.20424
74.
WangC.BowenD. J.KardiaS. L. (2005). Research and practice opportunities at the intersection of health education, health behavior, and genomics. Health Education & Behavior, 32, 686–701. doi:10.1177/1090198105278827
75.
WeissB. D. (2007). Health literacy and patient safety: Help patients understand. Manual for clinicians (2nd ed.). Chicago, IL: American Medical Association Foundation.
76.
WilliamsJ. R.YehV. M.BruceM. A.SzetelaC.UkoliF.WilkinsC. H.KripalaniS. (2018). Precision medicine: Familiarity, perceived health drivers, and genetic testing considerations across health literacy levels in a diverse sample. Journal of Genetic Counseling, 28, 59–69. doi:10.1007/s10897-018-0291-z
77.
WolfM. S.ParkerR.RatzanS. (2008). Literacy and public health. In S. R. Quah(Ed.), International encyclopedia of public health (pp. 98–104). Dublin, Ireland: Elsevier Press.
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
